Login
Sign up

[ARS] Celularity Inc SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

11/07/2025 - 01:19 PM

ARS - Celularity Inc

ARS Filing - Celularity Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Celularity Inc (CELU)

Acceptance Date: 2025-11-07T13:19:07.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Celularity Inc

NASDAQ:CELU

CELU Rankings

#5512 Ranked by Market Cap

N/A Ranked by Dividends

CELU Latest News

Oct 30, 2025

Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care

Oct 14, 2025

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

Sep 3, 2025

Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance

Aug 22, 2025

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Aug 18, 2025

Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt

CELU Latest SEC Filings

Nov 7, 2025

[S-8] Celularity Inc Employee Benefit Plan Registration

Nov 7, 2025

[DEF 14A] Celularity Inc Definitive Proxy Statement

Oct 28, 2025

[8-K] Celularity Inc Reports Material Event

CELU Stock Data

Market Cap 45.11M

Float 16.01M

Insiders Ownership 50.57%

Institutions Ownership 13.14%

Short Percent 6.33%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City FLORHAM PARK